Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 9.08
-0.05 (-0.59%)
Jul 17, 2026, 5:35 PM CET
Grifols Market Cap
Grifols has a market cap or net worth of €5.49 billion as of July 17, 2026. Its market cap has decreased by -25.46% in one year.
Market Cap
5.49B
Enterprise Value
16.85B
Revenue
7.44B
Ranking
n/a
PE Ratio
14.89
Stock Price
€9.08
ChartMarket Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 5.49B, an increase of 653.00%. That is a compound annual growth rate of 10.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 5.49B | -16.04% |
| Dec 31, 2025 | 6.54B | 15.08% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 2.74B |
| Almirall | 2.34B |
| Faes Farma | 1.35B |
| Pharma Mar | 1.32B |
| Clínica Baviera | 906.65M |
| Oryzon Genomics | 239.15M |
| Prim, S.A. | 226.28M |
| Laboratorio Reig Jofre | 215.74M |